Development prospects of the Russian pharmaceutical industry in the modern context

This article focuses on the prospects for the development of the Russian pharmaceutical industry in the modern economic and geopolitical context. The authors analyze the pharmaceutical market of the Russian Federation in the context of the importance of this industry for ensuring national security in the field of healthcare in times of crises brought about by various reasons. The objective of the present paper was to determine the vector of development of the Russian pharmaceutical market based on the identified structural characteristics and trends in the development of the industry in a rapidly changing geopolitical situation. As demonstrated by the analysis, the Russian pharmaceutical industry is critically dependent on the import of finished dosage forms and substances and is characterized by a consistently high share of noninnovative drugs, which in fact determines the main directions of development of the industry in the medium and long term. The article is based on the following methods: analyzing the results of monitoring the pharmaceutical market of the Russian Federation, analyzing statistical data and expert assessments of development trends in the global and national pharmaceutical industry. The authors come to the conclusion that it is necessary to promptly revise the structure and scope of government investment in the transition of the pharmaceutical industry to an innovative production model, which will allow Russian manufacturers both to meet the needs of Russian healthcare and support the fast-growing segment of the national economy and to become an exporter in the international pharmaceutical market.

1. Pharmaceutical Market. Analytical review // National Credit Ratings (NCR). Analytical review. Corporate sector. URL: https://ratings.ru/files/research/NCR_Pharma_Sep2019.pdf (Accessed 26 August 2023).

2. Ibid.

3. Ibid.

4. Russia’s Pharmaceutical Market 2021. Annual report // DSM Group. Analytical reports. URL: https://dsm.ru/docs/presentations/Фармрынок_2021_Итоги_12месяцев.pdf (Accessed 26 August 2023).

5. Ibid.

6. Pharmaceutical Market of the Russian Federation — Will the State Help Us? // National Credit Ratings (NCR). Analytical review. 2020. URL: https://www.ra-national.ru/ru/node/63747 (Accessed 26 August 2023).

7. Pharmaceutical Market of the Russian Federation — Will the State Help Us? // National Credit Ratings (NCR). Analytical review. 2020 URL: https://www.ra-national.ru/ru/node/63747 (Accessed 27 August 2023).

8. Russia’s Pharmaceutical Market 2021. Annual report // DSM Group. Analytical reports. URL: https://dsm.ru/docs/presentations/Фармрынок_2021_Итоги_12месяцев.pdf (Accessed 28 August 2023).

9. Ibid.

10. Development of the pharmaceutical and medical industry of the Russian Federation until 2020 and beyond / Federal program. Moscow. 2011. URL: https://base.garant.ru/12183677/#block_10000 (Accessed 01 September 2023).

11. Russia’s Pharmaceutical Market 2021. Annual report // DSM Group. Analytical reports. URL: https://dsm.ru/docs/presentations/Фармрынок_2021_Итоги_12месяцев.pdf (Accessed 02 September 2023).

12. Russia’s Pharmaceutical Market 2021. Annual report // DSM Group. Analytical reports. URL: https://dsm.ru/docs/presentations/Фармрынок_2021_Итоги_12месяцев.pdf (Accessed 02 September 2023).

13. Ibid.

14. Federal Law ‘On the Contract System in the Field of Procurement of Goods, Works, Services to Meet State and Municipal Needs’ dated 5 June 2013. № 44-FZ (as amended as of 24 February 2021) // Corpus of Legislation of the Russian Federation. 2013. № 54. p. 1652; 2013. № 27. p. 3480; 2020. № 14. p. 2037; 2021. № 9. p. 1467. URL: http://www.consultant.ru/document/cons_doc_LAW_144624/ (Accessed 02 September 2023).

15. Pharmaceutical Market. Analytical review // National Credit Ratings (NCR). Analytical review. Corporate sector. URL: file:///C:/Users/User/Downloads/NCR_Pharma_Sep2019.pdf (Accessed 03 September 2023).

16. Pharmaceutical Market. Analytical review // National Credit Ratings (NCR). Analytical review. Corporate sector. URL: file:///C:/Users/User/Downloads/NCR_Pharma_Sep2019.pdf (Accessed 05 September 2023).

17. Russia’s Pharmaceutical Market 2021. Annual report // DSM Group. Analytical reports. URL: https://dsm.ru/docs/presentations/Фармрынок_2021_Итоги_12месяцев.pdf (Accessed 07 September 2023).

18. Russia’s Pharmaceutical Market 2020 // DSM Group. Analytical reports. URL: https://dsm.ru/docs/analytics/2020_Report_rus.pdf?ysclid=l2tk7ed5bm (Accessed 07 September 2023).

19. Ibid.

20. Ibid.

21. Foreign Pharmaceutical Companies that Announced Changes in their Operations in Russia // Pharmvestnik Information and Analytics Portal. Analytics. URL: https://pharmvestnik.ru/content/news/Kakie-zarubejnyeREFERENCESfarmkompanii-soobshili-ob-izmenenii-v-rabote-na- rossiiskom-rynke.html (Accessed 10 September 2023).

22. Russia’s Pharmaceutical Market 2020 // DSM Group. Analytical reports. URL: https://dsm.ru/docs/analytics/2020_Report_rus.pdf?ysclid=l2tk7ed5bm (Accessed 11 September 2023).

23. Russia’s Pharmaceutical Market 2021. Annual report // DSM Group. Analytical reports. URL: https://dsm.ru/docs/presentations/Фармрынок_2021_Итоги_12месяцев.pdf (Accessed 11 September 2023).

24. Pharma-2022: Launching the Strategy for the Development of the Pharmaceutical Industry until 2030. Post-release // Kommersant Events. 2022. Events. URL: https://events.kommersant.ru/events/zapusk-strategii-farma-2030/(Accessed 11 September 2023).

25. Decree of the Government of the Russian Federation of December 29, 2021 No. 2544 On amendments to the state program of the Russian Federation ‘Development of the pharmaceutical and medical industry’ // Corpus of Legislation of the Russian Federation. 2022. № 1. p. 236. URL: https://szrf.ru/szrf/doc.php?nb=100&issid=1002022001010&docid=236 (Accessed 13 September 2023).

26. World Biomedical Clusters: Success Factors and Best Practices / Islankina E.A., Kutsenko E.S., Filina F.N., Pankevich V.I., et al.; International Medical Cluster Foundation; National Research University Higher School of Economics. Moscow: National Research University Higher School of Economics, 2019. p. 160

27. New Technology Solutions and Moving Away from Parallel Imports — Results of the First Day of the Biotechmed Forum // BIOTECHMED. 2022. News. URL: https://biotechmedconf.ru/2022/09/20/novye-tehnologicheskie-resheniyai-otkaz-ot-parallelnogo-importa-itogi-pervogo-dnya-foruma-biotehmed/ (Accessed 15 September 2023).

28. The Russian Pharmaceutical and Medical Industries Proven Ready to Face Challenges // Website of the Government of Russia. News. 21 September 2022. URL: http://government.ru/news/46569/ (Accessed 15 September 2023).

29. The Russian Pharmaceutical Industry Proven Ready to Face New Challenges — Manturov // Expert.ru / Russian Industry. Pharmaceuticals. 21 September 2022. URL: https://expert.ru/2022/09/21/manturov-otmetil-chtorossiyskaya-farmpromyshlennost-dokazala-gotovnost-k-novym-vyzovam/ (Accessed 15 September 2023).